Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections

被引：15
|
作者：
Claros, Marina [1 ]
Citron, Diane M. [2 ]
Goldstein, Ellie J. C. [2 ,3 ]
Merriam, C. Vreni [2 ]
Tyrrell, Kerin L. [2 ]
机构：
[1] Roche Diagnost Int AG, Rotkreuz, Switzerland
[2] R M Alden Res Lab, Culver City, CA 90230 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2013年 / 76卷 / 04期
关键词：
Anaerobes; Diabetic foot infection; Intra-abdominal infection; Resistance; Finegoldia magna; Bacteroides fragilis; Levofloxacin; Ertapenem; CARBAPENEMS; RESISTANCE;
D O I：
10.1016/j.diagmicrobio.2013.04.025
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Few labs isolate and perform susceptibility tests on anaerobes; therefore, we studied the differences between 1185 anaerobes isolated from complicated intra-abdominal infections and 470 isolated from moderate to severe diabetic foot infections. They differed markedly in the distribution of species, including Bacteroides fragilis and anaerobic Gram-positive cocci, as well as in resistance patterns, especially to fluoroquinolones. (c) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：546 / 548
页数：3
相关论文
共 50 条
  • [31] Critical evaluation of ceftolozane-tazobactam for complicated urinary tract and intra-abdominal infections
    Giancola, Stephanie E.
    Mahoney, Monica V.
    Bias, Tiffany E.
    Hirsch, Elizabeth B.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 787 - 797
  • [32] The Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections With a Positive Culture for Enterococcus faecalis
    Fabre, Valeria
    Nemati, Koorosh
    Avdic, Edina
    Cosgrove, Sara E.
    Amoah, Joe
    Tamma, Pranita D.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (01):
  • [33] Antimicrobial susceptibility of Gram-negative bacilli of community acquired intra-abdominal infections in a hospital at Buenos Aires, Argentina
    Morganti, Laura
    Cordova, Ezequiel
    Cassini, Elsa
    Gomez, Nora
    Lopez Moral, Laura
    Badia, Marcela
    Rodriguez, Claudia
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2016, 29 (04) : 202 - 205
  • [34] Treatment Modalities and Antimicrobial Stewardship Initiatives in the Management of Intra-Abdominal Infections
    Hoffmann, Charles
    Zak, Matthew
    Avery, Lisa
    Brown, Jack
    ANTIBIOTICS-BASEL, 2016, 5 (01):
  • [35] Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study
    De Waele, J. J.
    Tellado, J. M.
    Alder, J.
    Reimnitz, P.
    Jensen, M.
    Hampel, B.
    Arvis, P.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (01) : 57 - 64
  • [36] Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015
    Karlowsky, James A.
    Hoban, Daryl J.
    Hackel, Meredith A.
    Lob, Sibylle H.
    Sahm, Daniel F.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (01) : 61 - 69
  • [37] Clinical Efficacy and Correlation of Clinical Outcomes With In Vitro Susceptibility for Anaerobic Bacteria in Patients With Complicated Intra-abdominal Infections Treated With Moxifloxacin
    Goldstein, Ellie J. C.
    Solomkin, Joseph S.
    Citron, Diane M.
    Alder, Jeffrey D.
    CLINICAL INFECTIOUS DISEASES, 2011, 53 (11) : 1074 - 1080
  • [38] Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infections
    Pelak, BA
    Woods, GL
    Teppler, H
    Friedland, I
    Bartizal, K
    Motyl, M
    JOURNAL OF CHEMOTHERAPY, 2002, 14 (03) : 227 - 233
  • [39] Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010-2011
    Hawser, Stephen
    Hoban, Daryl J.
    Badal, Robert E.
    Bouchillon, Samuel K.
    Biedenbach, Douglas
    Hackel, Meredith
    Morrissey, Ian
    JOURNAL OF CHEMOTHERAPY, 2015, 27 (02) : 67 - 73
  • [40] Efficacy ratio: A tool to enhance optimal antimicrobial use for intra-abdominal infections
    Sabu, Priyanka
    Elangovan, Divyaa
    Pragasam, Agila Kumari
    Bakthavatchalam, Yamuna Devi
    Rodrigues, Camilla
    Chitnis, D. S.
    Chaudhuri, Bhaskar Narayan
    Veeraraghavan, Balaji
    INDIAN JOURNAL OF PHARMACOLOGY, 2018, 50 (06) : 332 - 335
12345